Related Experiment Video
Updated: Feb 21, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Antithrombotic therapy in the elderly - are there differences?]
1Department of Cardiology, Ondokuz Mayıs University Faculty of Medicine, Samsun, Turkey. msahin@omu.edu.tr.
Elderly populations face increasing risks of atherothrombotic disease. Optimal antithrombotic therapy is crucial but challenging due to increased vulnerability to adverse effects in older adults.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Pharmacology
Background:
- Atherothrombotic diseases, such as heart attack and stroke, are a significant health concern, particularly in aging populations.
- Antithrombotic therapy is essential for preventing atherothrombosis, but its application in elderly patients presents unique challenges.
- The growing elderly demographic worldwide necessitates a deeper understanding of age-specific treatment strategies.
Purpose of the Study:
- To review and discuss the complexities of antithrombotic therapy selection in elderly patients.
- To highlight the balance between the benefits and risks of antithrombotic agents in older individuals.
- To emphasize the importance of tailored antithrombotic management strategies for the elderly.
Main Methods:
- This review synthesizes current literature on atherothrombosis and antithrombotic treatments in elderly populations.
- Key considerations regarding drug efficacy, safety profiles, and patient-specific factors were analyzed.
- Clinical guidelines and research findings related to antiplatelet and anticoagulant therapies were evaluated.
Main Results:
- While antiplatelet therapy offers proven benefits in preventing atherothrombotic events, elderly patients exhibit a higher susceptibility to bleeding complications.
- Individualized risk-benefit assessments are critical for selecting appropriate antithrombotic agents in this demographic.
- Age-related physiological changes can influence drug pharmacokinetics and pharmacodynamics, impacting treatment outcomes.
Conclusions:
- Effective antithrombotic management in the elderly requires careful consideration of their increased vulnerability to adverse drug events.
- Personalized therapeutic approaches are paramount to optimize the prevention of atherothrombosis while minimizing treatment-related risks.
- Further research is warranted to refine antithrombotic strategies specifically for the aging population.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Venous Thrombosis III: Interprofessional Care
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion